Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
A further connection between lifestyle factors and breast cancer is revealed in two new studies presented during the San Antonio Breast Cancer Symposium.
The second press conference held at the San Antonio Breast Cancer Symposium featured four studies that looked at emerging therapies in the treatment of breast cancer.
Magnetic resonance imaging (MRI) coupled with mammography detects almost all cancers at an early stage, reducing the incidence of advanced breast cancer in high-risk women, according to a study presented at the San Antonio Breast Cancer Symposium.
LBBC is happy to attend the San Antonio Breast Cancer Symposium (SABCS) and bring you the latest information coming out of this meeting.
HHS Secretary Kathleen Sebelius issued a statement yesterday on new breast cancer screening recommendations from the U.S. Preventive Services Task Force.
On November 16, 2009, The United States Preventive Services Task Force (USPSTF) announced that it is changing its guidelines for mammography and no longer recommends routine screening for women between the ages of 40 and 49 who are at average risk for developing breast cancer.
Single-agent chemotherapy is recommended over combination for metastatic disease, says the European School of Oncology’s Metastatic Breast Cancer Task Force.
3-T MRI detected more early breast cancers than mammography and sonography, a review study showed.
We encourage you to join the efforts of our friends at the Metastatic Breast Cancer Network to declare October 13 National Metastatic Breast Cancer Awareness Day.
Olaparib, a PARP inhibitor pill, worked powerfully against BRCA-related metastatic breast cancers, an American Society of Clinical Oncology (ASCO) study showed.